Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2023 10
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Congenital angiokeratoma.
Mansilla-Polo M, Martín-Torregrosa D. Mansilla-Polo M, et al. Among authors: martin torregrosa d. An Pediatr (Engl Ed). 2024 Apr 4:S2341-2879(24)00113-3. doi: 10.1016/j.anpede.2024.03.048. Online ahead of print. An Pediatr (Engl Ed). 2024. PMID: 38580593 Free article. No abstract available.
Atypical targetoid lesions.
Mansilla-Polo M, Martín-Torregrosa D, Abril-Pérez C. Mansilla-Polo M, et al. Among authors: martin torregrosa d. Semergen. 2024 Mar 29;50(6):102228. doi: 10.1016/j.semerg.2024.102228. Online ahead of print. Semergen. 2024. PMID: 38554608 No abstract available.
Chikungunya fever with a positive tourniquet test: a novel description.
Mansilla-Polo M, Torres-Navarro I, Martín-Torregrosa D, López-Davia J, Botella-Estrada R. Mansilla-Polo M, et al. Among authors: martin torregrosa d. Clin Exp Dermatol. 2024 Mar 18:llae089. doi: 10.1093/ced/llae089. Online ahead of print. Clin Exp Dermatol. 2024. PMID: 38494642 No abstract available.
Efficacy of Omalizumab for the treatment of Bullous Pemphigoid. Spanish multicenter real-world experience.
Aguado Vázquez Á, Estébanez Corrales A, Melgosa-Ramos FJ, Mascaró Galy JM, Fulgencio-Barbarin J, Bosch Amate X, Curto Barredo L, Blanes-Martínez M, Ruiz Villaverde R, Ballester Martínez A, Martín-Torregrosa D, Castaño Fernández JL, Cabeza Martínez R, Pérez-Ferriols A, Ramos Rodríguez D, Boix Vilanova J, Melé-Ninot G, Expósito Serrano V, Alonso AE, Mateu-Puchades A. Aguado Vázquez Á, et al. Among authors: martin torregrosa d. Clin Exp Dermatol. 2024 Mar 2:llae067. doi: 10.1093/ced/llae067. Online ahead of print. Clin Exp Dermatol. 2024. PMID: 38430106
Symmetric Drug-Related Intertriginous and Flexural Exanthema.
Mansilla Polo M, Martín-Torregrosa D. Mansilla Polo M, et al. Among authors: martin torregrosa d. N Engl J Med. 2024 Feb 15;390(7):e17. doi: 10.1056/NEJMicm2310034. N Engl J Med. 2024. PMID: 38354144 No abstract available.
Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort study.
Lasheras-Pérez MA, Palacios-Diaz RD, González-Delgado VA, Cobreros LV, Pereira-Resquin Galván GO, Miquel-Miquel J, Labrandero Hoyos C, Zaragoza Ninet V, Melgosa Ramos FJ, Sánchez-Motilla JM, Navarro-Blanco F, Martín-Torregrosa D, Botella-Estrada R, Rodríguez-Serna M. Lasheras-Pérez MA, et al. Among authors: martin torregrosa d. Int J Dermatol. 2024 Mar;63(3):402-404. doi: 10.1111/ijd.17030. Epub 2024 Jan 16. Int J Dermatol. 2024. PMID: 38229523 No abstract available.
Dermatologic Consultations for Patients Hospitalized in Non-Dermatologic Wards: Results of a 384-Patient Cross-Sectional Study From a Tertiary Referral Hospital.
Mansilla-Polo M, Navarro-Blanco F, Martín-Torregrosa D, Botella-Estrada R. Mansilla-Polo M, et al. Among authors: martin torregrosa d. Actas Dermosifiliogr. 2023 Dec 28:S0001-7310(23)01007-4. doi: 10.1016/j.ad.2023.11.021. Online ahead of print. Actas Dermosifiliogr. 2023. PMID: 38159838 English, Spanish. No abstract available.
20 results